![]() |
Trials |
A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6-methylguanine DNA methyltransferase)Cancer type: Glioblastoma Phase: II Principal Investigator: Brandal Petter Country: NO Keywords: Norway, Oslo, Glioblastoma, MGMT methylated Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02667587?term=ca209-548&rank=1 |